期刊文献+

siRNA下调EIF4E基因对人乳腺癌MDA-MB-231细胞增殖和周期的影响 被引量:5

The effects of EIF4E gene down-regulation induced by siRNA on the proliferation and cell cycle of human breast cancer cell line MDA-MB-231
原文传递
导出
摘要 目的:应用小干扰RNA(small interfering RNA, siRNA)乳腺癌MDA-MB-231细胞中真核细胞翻译起始因子4E (eukaryotic translation initiation factor 4E, EIF 4E )基因的表达,探讨其对乳腺癌细胞增殖和生长周期的影响。方法:构建针对EIF 4E 基因的siRNA表达质粒,采用脂质体法将表达质粒pGPU6/GFP/Neo-EIF4E转染人乳腺癌MDA-MB-231细胞;分别采用RT-PCR、Western 印迹法和免疫细胞化学法检测转染EIF4E siRNA后, 对MDA-MB-231细胞中EIF4E及cyclinD1 mRNA和蛋白的表达水平的影响;MTT法、平板克隆形成实验和FCM检测MDA-MB-231细胞增殖活性、克隆形成率及细胞周期。结果:成功构建EIF4E siRNA表达质粒。RT-PCR、Western 印迹法和免疫细胞化学法检测结果显示,MDA-MB-231细胞中EIF4E及cyclinD1 mRNA和蛋白表达均明显下降(P <0.05)。转染EIF4E siRNA组细胞生长缓慢,集落形成数明显减少,与空白对照组和转染空载体组比较,差异有统计学意义(P<0.05)。FCM检测结果显示,EIF4E siRNA转染组G1期细胞所占百分比为(71.30±0.47)%, 较空白对照组的( 53.10±0.43)%明显增加,而S期细胞所占百分比为(12.53±0.13)%,较空白对照组的(26.47±0.38)%明显减少(P<0.05)。结论:EIF4E siRNA可显著下调EIF4E基因在乳腺癌MDA-MB-231细胞中的表达水平,在一定程度上抑制乳腺癌细胞的增殖,有可能成为临床治疗乳腺癌的靶点之一。 Objective:To study the effect of down-regulation of eukaryotic translation initiation factor 4E(EIF4E) induced by the siRNA expression plasmid on the proliferation and cell cycle of human breast cancer cell line MDA-MB-231.Methods:The siRNA expression plasmid pGPU6/GFP/Neo-EIF4E was constructed and then transfected into breast cancer MDA-MB-231 cells by LipofectAMINE2000.The expressions of EIF4E and cyclin D1 mRNAs and proteins were examined by RT-PCR,Western blotting and the immunocytochemistry method,respectively.The MTT method,plate colony formation assay and flow cytometry were performed to detect the proliferation ability,cell colony formation rate and cell cycle distribution of MDA-MB-231 cells transfected with siRNA expression plasmid.Results:The siRNA expression plasmid pGPU6/GFP/Neo-EIF4E was constructed successfully.The expressions of EIF4E and cyclin D1 mRNAs and proteins were all decreased markedly after transfection with pGPU6/GFP/Neo-EIF4E(P0.05).The growth of MDA-MB-231 cells in the pGPU6/GFP/Neo-EIF4E-tranfected group was inhibited and the cell colony formation rate was statistically decreased(P0.05) as compared with those in the blank control and the pGPU6/GFP-transfected groups.The result of flow cytometry showed that the percentage of cells in G1 phase in the pGPU6/GFP/Neo-EIF4E-tranfected group was higher than that in the blank control group(71.30%±0.47% vs 53.10%±0.43%);however,the percentage of cells in S phase was signifcantly lower(12.53%±0.13% vs 26.47%±0.38%,P0.05).Conclusion:EIF4E siRNA can down-regulate EIF4E gene expression in human breast cancer MDA-MB-231 cells,suppress cell proliferation to some extent,and increase the number of cells in G1 phase with a decreased number of cells in S phase.EIF4E gene may become one of the important molecular targets to breast cancer.
出处 《肿瘤》 CAS CSCD 北大核心 2011年第3期197-202,共6页 Tumor
关键词 乳腺肿瘤 RNA 小分子干扰 细胞凋亡 真核细胞翻译起始因子 细胞 MDA-MB-231 Breast neoplasms RNA small interfering Apoptosis Eukaryotic translation initiation factor Cells MDA-MB-231
  • 相关文献

参考文献13

  • 1DONG K,WANG R,WANG X,et al.Tumorspecific RNAi targeting eIF4E suppresses tumor growth,induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells[J].Breast Cancer Res Treat,2009,113(3):443-4S6.
  • 2SONI A,AKCAKANAT A,SINGH G,et al.EIF4E knockdown decreases breast cancer cell growth without activating Akt signaling[J].Mol Cancer Ther,2008,7(7):1782-1788.
  • 3ZHOU S,WANG G P,LIU C,et al.Eukaryotic Initiation factor 4E (EIF4E) and angiogenesis:prognostic markers for breast cancer[J].BMC Cancer,2006,6:231.
  • 4SHAWBER C J,FUNAHASHI Y,FRANCISO E,et al.Notch alters VEGF responsiveness in human and murine endothelial cells by direct regulation of VEGFR-3 expression[J].J Clin Invest,2007,117(11):3369-3382.
  • 5古浠伶,曹友德.shRNA对乳腺癌细胞VEGF-C表达的抑制作用[J].中国肿瘤临床,2009,36(3):163-167. 被引量:4
  • 6KLEINER K E,KRISHNANL P,TUBBS J,et al.Tissue microarray analysis of eIF4E and its downstream effector proteins in human breast cancer[J].J Exp Clin Cancer Res,2009,28:5.
  • 7COLEMAN L J,PETER M B,TESLL T J,et al.Combined analysis of eIF4E and 4E-binding protein expression predicts breast cancer survival and estimates eIF4E activity[J].Br J Cancer,2009,100(9):1393-1399.
  • 8LI Y,YUE P,DENG X,et al.Protein phosphatase 2A negatively regulates eukaryotic initiation factor4E phosphorylation and eIF4F assembly through direct dephosphorylation of Mnk and e1F4E[J].Neoplasia,2010,12(10):848-855.
  • 9盛世乐,黄钢.VEGF上调survivin和bcl-2表达及抑制乳腺癌细胞凋亡的机制探讨[J].肿瘤,2005,25(6):525-529. 被引量:17
  • 10TANAJA P,MAGLIC D,KAI F,et al.Classical and novel prognostic markers for breast cancer and their clinical significance[J].Clin Med Insights Oncol,2010,4:15-34.

二级参考文献24

  • 1肖炜明,施瑞华,丁岩冰,龚卫娟,丁永玲,薛艳.胃癌组织中EGFR和COX-2表达的意义及其相关性[J].世界华人消化杂志,2007,15(2):123-128. 被引量:14
  • 2Zeng Y, Opeskin K, Baldwin ME, et al. Expression of vascular endothelial growth factor receptor-3 by lymphatic endothelial cells is associated with lymph node metastasis in prostate cancer [J]. Clin Cancer Res, 2004, 10(15): 5137-5144.
  • 3Saharinen P, Tammela T, Karkkainen MJ, et al. Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation[J]. Trends Immunol, 2004, 25(7): 387-395.
  • 4Benest AV, Harper SJ, Herttuala SY, et al. VEGF-C induced angiogenesis preferentially occurs at a distance from lymphangiogenesis[J]. Cardiovasc Res, 2008, 78(2): 315 - 323.
  • 5Kinoshita J, Kitamura K, Kabashima A, et al. Clinical significance of vascular endothelial growth factor-C(VEGF-C) in breast cancer[J]. Breast Cancer Res Treat, 2001, 66(2): 159-164.
  • 6Hirakawa S, Brown LF, Kodama S, et al. VEGF-C - induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites[J]. Blood, 2007, 109(3): 1010-1017.
  • 7He Y, Rajantie I, Pajusola K, et al. Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels[J]. Cancer Res, 2005, 65(11): 4739-4746.
  • 8Pytowski B, Goldman J, Persaud K, et al. Complete and specific inhibition of adult lymphatic regeneration by a novel VEGFR-3 neutralizing antibody[J].J Natl Cancer Inst, 2005, 97(1): 14-21.
  • 9LinJ, Lalani AS, Harding TC, et al. Inhibition of lymphogenous metastasis using adeno-associated virus-mediated gene transfer of a soluble VEGFR-3 decoy receptor[J]. Cancer Res, 2005, 65 (15) :6901-6909.
  • 10Roberts N, Kloos B, CasseUa M, et al. Inhibition of VEGFR-3 activation with the antagonistic antibody more potendy suppresses lymph node and distant metastases than inactivation of VEG-FR-2[J]. Cancer Res, 2006, 66(5): 2650-2657.

共引文献23

同被引文献24

引证文献5

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部